Results 101 to 110 of about 1,206 (166)

Treatment-emergent major adverse cardiovascular and thromboembolic events were infrequent during clinical trials of pegloticase. [PDF]

Rheumatology (Oxford)
Troum OM, Duong M, Obermeyer K, Padnick-Silver L, LaMoreaux B.   +4 more
europepmc   +1 more source

NUR 155.01: Meeting Adult Physiological Needs I [PDF]

, 2006
Ogilvie, LeAnn
core   +1 more source

Sarcoid-Like Reactions [PDF]

, 2011
Shweta Nag
core   +1 more source

2024 Update of Chinese Guidelines for Management of Hyperuricemia and Gout Part II: Recommendations for Patients With Common Comorbidities. [PDF]

Int J Rheum Dis
Li C, Sun M, Liu Z, Li D, Wang C, Tian Z, Dai Y, Feng Z, Xu C, Zhao D, Wei F, Ban B, Xie C, An Z, Liu J, Li Z, He Y, Li X, Yan F, Han L, Ma L, Cheng X, Liu T, Luo X, Luo X, Cui L, Gong Y, Wang C, Chen Y, Lyu Z, Yip RML, Zhao J.   +31 more
europepmc   +1 more source

Colchicine and the risk of major adverse cardiovascular events in patients with gout and Type 2 diabetes: A nationwide cohort study. [PDF]

J Intern Med
Jeon M, Cho Y, Bea S, You W, Cho SK, Ryu S, Chang Y, Shin JY.   +7 more
europepmc   +1 more source

Association Between HLA-B5801 Positivity and Patient Characteristics and Clinical Outcomes in Gout. [PDF]

In Vivo
Ahn SS, Kim JA, Bae K.
europepmc   +1 more source

DRESS Syndrome - Rare but Potentially Fatal Drug Reaction. [PDF]

Hawaii J Health Soc Welf
Fukuyama TH, Yamat BR, Tokeshi J.
europepmc   +1 more source

Group-based trajectory modeling to assess adherence to chronic urate-lowering therapies among commercially insured US adults with gout. [PDF]

J Manag Care Spec Pharm
Rizk JG, Qato DM, Bingham CO, dosReis S.
europepmc   +1 more source

Gouty tophi of the pinna. [PDF]

BMJ Case Rep
Gurney M, Morris S, Saw K.
europepmc   +1 more source

Roles of traditional Chinese medicine extracts in hyperuricemia and gout treatment: Mechanisms and clinical applications. [PDF]

World J Gastroenterol
Wang YB, Jin CZ.
europepmc   +1 more source